CERES INC. Logo

CERES INC.

Develops online media platforms connecting consumers with advertisers through a rewards system.

3696 | T

Overview

Corporate Details

ISIN(s):
JP3423570005
LEI:
Country:
Japan
Address:
渋谷区桜丘町1番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Ceres Inc. is an internet marketing company operating under the mission of "Enriching the world through internet marketing." The company's core business involves the development and management of online media platforms. Its flagship service is "Moppy," a point media site where users can accumulate points through various online activities and exchange them for rewards. By connecting a large consumer base with advertisers, Ceres provides marketing and user acquisition solutions for businesses while offering value to its platform users.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-13 05:30
Report Publication Announcement
確認書
Japanese 8.2 KB
2025-08-13 05:29
Interim Report
半期報告書-第21期(2025/01/01-2025/12/31)
Japanese 228.9 KB
2025-07-18 08:49
M&A Activity
臨時報告書
Japanese 22.5 KB
2025-07-01 08:56
Major Shareholding Notification
大量保有報告書
Japanese 34.4 KB
2025-05-08 09:40
Regulatory News Service
臨時報告書
Japanese 19.1 KB
2025-04-21 09:17
Share Issue/Capital Change
臨時報告書
Japanese 30.8 KB
2025-03-26 06:24
Governance Information
内部統制報告書-第20期(2024/01/01-2024/12/31)
Japanese 23.2 KB
2025-03-26 06:18
Registration Form
確認書
Japanese 8.1 KB
2025-03-26 06:10
Annual Report
有価証券報告書-第20期(2024/01/01-2024/12/31)
Japanese 1.1 MB
2025-03-26 05:15
Post-Annual General Meeting Information
臨時報告書
Japanese 24.6 KB
2025-02-14 09:14
Regulatory News Service
臨時報告書
Japanese 19.7 KB
2025-02-14 09:14
Regulatory News Service
臨時報告書
Japanese 18.0 KB
2025-01-27 09:12
Regulatory News Service
臨時報告書
Japanese 22.6 KB
2024-08-13 08:58
Report Publication Announcement
確認書
Japanese 8.3 KB
2024-08-13 08:57
Interim Report
半期報告書-第20期(2024/01/01-2024/12/31)
Japanese 197.3 KB

Automate Your Workflow. Get a real-time feed of all CERES INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CERES INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CERES INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Eezy Oyj Logo
HR services firm for the full employment lifecycle, from recruitment to freelancer support.
Finland
EEZY
Elicio Therapeutics, Inc. Logo
Develops lymph node-targeted immunotherapies for aggressive, KRAS-driven cancers.
United States of America
ELTX
enCore Energy Corp. Logo
American uranium producer using ISR technology to fuel the U.S. nuclear energy sector.
United States of America
EU
ENERGY FUELS INC Logo
A leading U.S. producer of uranium and rare earth elements for EVs, defense, and technology.
United States of America
UUUU
ENIGMATIG LTD Logo
Global expansion and regulatory compliance consultancy for the financial services industry.
United States of America
EGG
Enjin Co., Ltd. Logo
PR firm for SMEs and medical institutions, offering consulting and a media matching platform.
Japan
7370
Ensol Biosciences Inc. Logo
Develops AI-discovered peptide drugs for cancer, osteoarthritis, and Alzheimer's disease.
South Korea
140610
Enveric Biosciences, Inc. Logo
Develops novel neuroplastogen drugs for severe mental health and addiction disorders.
United States of America
ENVB
Eutilex Co.,Ltd. Logo
Develops T-cell and antibody immunotherapies for cancer and autoimmune diseases.
South Korea
263050
Evaxion A/S Logo
Develops AI-powered, personalized vaccines for cancer and infectious diseases.
United States of America
EVAX

Talk to a Data Expert

Have a question? We'll get back to you promptly.